logo
logo

Entact Bio Appoints Ruben Tommasi As Chief Scientific Officer

Sep 17, 2024•11 months ago

Position

Chief Scientific Officer

Company

Entact Bio

Ruben Tommasi
WatertownBiotechnology

Description

Entact Bio announced the appointment of Ruben Tommasi, Ph.D., as Chief Scientific Officer. Dr. Tommasi joins Entact with three decades of experience in the life sciences industry, having held a series of leadership roles driving drug discovery across therapeutic areas at global pharmaceutical companies and innovative biotechs.

Company Information

Company

Entact Bio

Location

65 Grove St. Suite 303

Watertown, South Dakota, United States

About

Entact Bio is developing a novel class of precision medicines that enhance the function of beneficial proteins. Launched by a founding team deeply rooted in deubiquitylase (DUB) biochemistry, chemical biology, disease biology, and small-molecule drug development, Entact has built its proprietary Encompass™ platform to create enhancement-targeting chimeric (ENTAC™) medicines. ENTACs leverage the natural ability of DUBs to regulate and enhance protein function. By harnessing the power of DUBs, Entact is expanding the universe of treatable diseases and creating new options for patients who are underserved by current therapeutic modalities.

Related People

Sign in to view contact details

Sign in to view contact details

Sign in to view contact details

Executive Insights

Based on hiring data
New executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months